The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prediction of recurrence in stage I EGFR mutation-positive NSCLC: Combination of CT appearance and selected co-occurring gene alterations by machine learning.
 
Akiko Tateishi
No Relationships to Disclose
 
Hidehito Horinouchi
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly; Merck Serono; MSD Oncology; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Abbvie; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Novocure; Seagen; Yuhan
Research Funding - A2 Healthcare (Inst); Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); BMKK (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Ken Takasawa
No Relationships to Disclose
 
Nobuji Kouno
No Relationships to Disclose
 
Takaaki Mizuno
No Relationships to Disclose
 
Yu Okubo
No Relationships to Disclose
 
Yukihiro Yoshida
No Relationships to Disclose
 
Shun-ichi Watanabe
No Relationships to Disclose
 
Mototaka Miyake
No Relationships to Disclose
 
Masahiko Kusumoto
Honoraria - Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/UCB Japan
Research Funding - Canon Medical System (Inst)
 
Koji Inaba
No Relationships to Disclose
 
Hiroshi Igaki
Honoraria - Accuray; Daiichi Sankyo/UCB Japan; Elekta; GE Healthcare; Himedic; Itochu; Varian Medical Systems
Consulting or Advisory Role - HekaBio
Research Funding - Children's Integrated Center for Success; Elekta; HekaBio
 
Yasushi Yatabe
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Chugai Pharma; Daiichi Sankyo/UCB Japan; MSD K.K
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; Chugai Pharma; Daiichi Sankyo/Astra Zeneca; MSD K.K
Research Funding - Konica Minolta; Merck; Thermo Fisher Scientific
 
Masami Mukai
No Relationships to Disclose
 
Katsuya Tanaka
No Relationships to Disclose
 
Naoki Mihara
No Relationships to Disclose
 
Kouya Shiraishi
No Relationships to Disclose
 
Takashi Kohno
Consulting or Advisory Role - Lilly Japan
Speakers' Bureau - Lilly Japan; Lilly Japan
Research Funding - Chugai Pharma; Guardant Health; Konica Minolta; Sysmex
Patents, Royalties, Other Intellectual Property - Patent fee from Foundation Medicine Inc; Patent fee from Riken Genesis/Amoy Diagnostics; Patent fee from ThermoFisher Scientific
 
Yuichiro Ohe
Leadership - JCOG; JSMO
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Celltrion; Chugai Pharma; Eisai; Kyowa Hakko Kirin; Lilly Japan; MSD; Nippon Kayaku; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Anheart Therapeutics; AstraZeneca; Celltrion; Chugai Pharma; Kyorin; Lilly Japan; Novartis; Ono Pharmaceutical; PharmaMar; PharmaMar; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Janssen (Inst); Lilly Japan (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Ryuji Hamamoto
No Relationships to Disclose